Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Glaukos (GKOS)

Glaukos Q2 2025 net sales rise 30% to $124.1 million; 2025 sales guidance raised

Positive Impact 4 of 5 earnings Written later

Glaukos reported record second-quarter 2025 net sales of $124.1 million, up 30% from $95.7 million a year earlier, and a net loss of $19.7 million, or $0.34 per diluted share, versus a $50.5 million loss ($1.00 per share) in the prior-year quarter. The company raised its full-year 2025 net sales guidance to $480 million to $486 million from $475 million to $485 million, and ended the quarter with $278.6 million in cash, short-term investments and restricted cash and no debt.

Key points

  • Q2 2025 net sales of $124.1 million, up 30% from $95.7 million in Q2 2024
  • Net loss of $19.7 million, or $0.34 per diluted share, compared with $50.5 million, or $1.00 per share, in Q2 2024
  • 2025 net sales guidance raised to $480 million to $486 million from $475 million to $485 million
  • Cash, short-term investments and restricted cash of $278.6 million at June 30, 2025, with no debt

The filing

CompanyGlaukos (GKOS)
Form8-K, current report
Filed with the SECJul 30, 2025, 4:10 PM ET
Accession number0001558370-25-009798

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.